| Dear Loyal Reader, I just released another potentially huge opportunity…
It's about a tiny biotech company…
That recently received a Fast Track designation from the FDA…
In a move that could help cure Type 1 diabetes.
If that happens, this company could corner a $150 billion market.
And this private company…
Recently agreed to merge with a public company…
That's trading for just $11 a share.
At that price, it's market cap is only $142 million.
If everything goes right, it could dominate a $150 billion market.
We're talking about potential "1,000% in 1-year" gains here.
Click here to see how you can get this…
And all of my small-cap recommendations. 
Regards,
Ian King
Editor, Strategic Fortunes
(c) 2021 Banyan Hill Publishing. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement. Any reproduction, copying, or redistribution, (electronic or otherwise) in whole or in part, is strictly prohibited without the express written permission of Banyan Hill Publishing. P.O. Box 8378, Delray Beach, FL 33482. (TEL: 866-584-4096) Legal Notice
The mailbox associated with this email address is not monitored, so please do not reply.
Your feedback is very important to us so if you would like to contact us with a question or comment, please click here: http://banyanhill.com/contact-us
Remove your email from this list: Click here to Unsubscribe
| | | |
No comments:
Post a Comment